Enzymotec Ltd.
Records under this name other than the patents Enzymotec Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,688,070 | Serine glycerophospholipid preparation and method for treatment of seizures Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,993,456 | Oil Blends, Processes for the Preparation Thereof and Their Use in Formulas Formerly held In force · High confidence | In force | High confidence | |
| US 10,898,525 | Krill Oil Preparations and Their Uses Formerly held In force · High confidence | In force | High confidence | |
| US 10,894,056 | Phospholipid preparations for the improvement of sleep Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,011,013 | Oil blends and processes for their preparation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,888,573 | Phospholipid preparations for the improvement of brain plasticity Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,324,187 | Stabilized Formulations of Phosphatidylserine Term ended Term ended Nov 6, 2026 · High confidence | Term ended | Term ended Nov 6, 2026 | High confidence |
| US 8,470,345 | Lipids Containing OMEGA-3 and OMEGA-6 Fatty Acids Term ended Term ended May 18, 2025 · High confidence | Term ended | Term ended May 18, 2025 | High confidence |
| US 7,935,365 | Glycerophospholipids for the improvement of cognitive functions Term ended Term ended Feb 17, 2025 · From the USPTO record | Term ended | Term ended Feb 17, 2025 | From the USPTO record |
| US 8,052,992 | Glycerophospholipids Containing OMEGA-3 and OMEGA-6 Fatty Acids and Their Use in the Treatment and Improvement of Cognitive Functions Term ended Term ended Oct 21, 2024 · High confidence | Term ended | Term ended Oct 21, 2024 | High confidence |